Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
2(66.7%)
N/A
1(33.3%)
3Total
Phase 1(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05599087Phase 1Unknown

Encapsulated Acellular System From Mesenchymal Stem Cells for Dental Pulp Regeneration

Role: collaborator

NCT04863183Phase 1Unknown

Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis

Role: collaborator

NCT03102879Not ApplicableCompleted

Encapsulated Mesenchymal Stem Cells for Dental Pulp Regeneration.

Role: collaborator

All 3 trials loaded